Back to TKPHF
GOLDMAN SACHS GROUP INC → TKPHF
GOLDMAN SACHS GROUP INC TKPHF Position History
Takeda Pharmaceutical Company Limited
Quarters held
22
Latest value
$14.3M
Q2 2026
Peak value
$64.6M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $21.6M |
| Q1 2025 | $43M |
| Q1 2025 | $14.5M |
| Q2 2025 | $10.7M |
| Q2 2025 | $44.1M |
| Q2 2025 | $14.8M |
| Q3 2025 | $48.8M |
| Q3 2025 | $13.8M |
| Q3 2025 | $9.9M |
| Q4 2025 | $14.6M |
| Q4 2025 | $48.3M |
| Q4 2025 | $11.9M |
| Q4 2025 | $11.9M |
| Q4 2025 | $48.3M |
| Q4 2025 | $14.6M |
| Q1 2026 | $1.3M |
| Q1 2026 | $22.8M |
| Q1 2026 | $64.6M |
| Q1 2026 | $16.7M |
| Q2 2026 | $15.7M |
| Q2 2026 | $52.2M |
| Q2 2026 | $14.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $14.3M | 892.5K | — | — |
| Q2 2026 | $52.2M | 3.26M | — | — |
| Q2 2026 | $15.7M | 976.9K | — | — |
| Q1 2026 | $16.7M | 899.0K | — | — |
| Q1 2026 | $64.6M | 3.49M | — | — |
| Q1 2026 | $22.8M | 1.23M | — | — |
| Q1 2026 | $1.3M | 36.2K | — | — |
| Q4 2025 | $14.6M | 939.4K | — | — |
| Q4 2025 | $48.3M | 3.10M | — | — |
| Q4 2025 | $11.9M | 766.2K | — | — |
| Q4 2025 | $11.9M | 766.2K | — | — |
| Q4 2025 | $48.3M | 3.10M | — | — |
| Q4 2025 | $14.6M | 938.8K | — | — |
| Q3 2025 | $9.9M | 678.7K | — | — |
| Q3 2025 | $13.8M | 943.2K | — | — |
| Q3 2025 | $48.8M | 3.33M | — | — |
| Q2 2025 | $14.8M | 959.7K | — | — |
| Q2 2025 | $44.1M | 2.85M | — | — |
| Q2 2025 | $10.7M | 691.7K | — | — |
| Q1 2025 | $14.5M | 975.3K | — | — |
| Q1 2025 | $43M | 2.89M | — | — |
| Q1 2025 | $21.6M | 1.45M | — | — |
Other funds holding TKPHF
$96.1M
$83.9M
$81.7M
$80.1M
$80.1M
$77.8M
$77.8M